HIGHLIGHTS
- who: Florian Bamberger from the University of Campania Luigi Vanvitelli, Italy have published the paper: Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and, in the Journal: (JOURNAL)
- what: This study showed that the use of RTX in BP is associated with longer survival indicating a small risk for lethal infections due to RTX .
SUMMARY
The period of 6 months after RTX administration was given special attention throughout all analyses of efficacy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.